182 related articles for article (PubMed ID: 30910317)
1. Dilatation of the main pancreatic duct as first manifestation of small pancreatic ductal adenocarcinomas detected in a hereditary pancreatic cancer surveillance program.
Vasen HFA; Boekestijn B; Ibrahim IS; Inderson A; Bonsing BA; de Vos Tot Nederveen Cappel WH; Feshtali S; Wasser MN
HPB (Oxford); 2019 Oct; 21(10):1371-1375. PubMed ID: 30910317
[TBL] [Abstract][Full Text] [Related]
2. Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers.
Vasen H; Ibrahim I; Ponce CG; Slater EP; Matthäi E; Carrato A; Earl J; Robbers K; van Mil AM; Potjer T; Bonsing BA; de Vos Tot Nederveen Cappel WH; Bergman W; Wasser M; Morreau H; Klöppel G; Schicker C; Steinkamp M; Figiel J; Esposito I; Mocci E; Vazquez-Sequeiros E; Sanjuanbenito A; Muñoz-Beltran M; Montans J; Langer P; Fendrich V; Bartsch DK
J Clin Oncol; 2016 Jun; 34(17):2010-9. PubMed ID: 27114589
[TBL] [Abstract][Full Text] [Related]
3. High Growth Rate of Pancreatic Ductal Adenocarcinoma in
Ibrahim IS; Wasser MN; Wu Y; Inderson A; de Vos Tot Nederveen Cappel WH; Morreau H; Hes FJ; Veenendaal RA; Putter H; Feshtali S; van Mil AM; Gruis NA; Tollenaar RA; Bergman W; Bonsing BA; Vasen HFA
Cancer Prev Res (Phila); 2018 Sep; 11(9):551-556. PubMed ID: 29991580
[No Abstract] [Full Text] [Related]
4. Missed pancreatic ductal adenocarcinoma: Assessment of early imaging findings on prediagnostic magnetic resonance imaging.
Jang KM; Kim SH; Kim YK; Song KD; Lee SJ; Choi D
Eur J Radiol; 2015 Aug; 84(8):1473-1479. PubMed ID: 26032128
[TBL] [Abstract][Full Text] [Related]
5. Risk of misdiagnosis and overtreatment in patients with main pancreatic duct dilatation and suspected combined/main-duct intraductal papillary mucinous neoplasms.
Crippa S; Pergolini I; Rubini C; Castelli P; Partelli S; Zardini C; Marchesini G; Zamboni G; Falconi M
Surgery; 2016 Apr; 159(4):1041-9. PubMed ID: 26704784
[TBL] [Abstract][Full Text] [Related]
6. Variation in precursor lesions of pancreatic cancer among high-risk groups.
Potjer TP; Schot I; Langer P; Heverhagen JT; Wasser MN; Slater EP; Klöppel G; Morreau HM; Bonsing BA; de Vos Tot Nederveen Cappel WH; Bargello M; Gress TM; Vasen HF; Bartsch DK; ;
Clin Cancer Res; 2013 Jan; 19(2):442-9. PubMed ID: 23172884
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological Meaning of Size of Main-Duct Dilatation in Intraductal Papillary Mucinous Neoplasm of Pancreas: Proposal of a Simplified Morphological Classification Based on the Investigation on the Size of Main Pancreatic Duct.
Kang MJ; Jang JY; Lee S; Park T; Lee SY; Kim SW
World J Surg; 2015 Aug; 39(8):2006-13. PubMed ID: 25894399
[TBL] [Abstract][Full Text] [Related]
8. Long-term yield of pancreatic cancer surveillance in high-risk individuals.
Overbeek KA; Levink IJM; Koopmann BDM; Harinck F; Konings ICAW; Ausems MGEM; Wagner A; Fockens P; van Eijck CH; Groot Koerkamp B; Busch ORC; Besselink MG; Bastiaansen BAJ; van Driel LMJW; Erler NS; Vleggaar FP; Poley JW; Cahen DL; van Hooft JE; Bruno MJ;
Gut; 2022 Jun; 71(6):1152-1160. PubMed ID: 33820756
[TBL] [Abstract][Full Text] [Related]
9. Clinical and radiologic characteristics of pancreatic head carcinoma without main pancreatic duct dilatation: using dual-phase contrast-enhanced CT scan.
Ko SE; Choi IY; Cha SH; Yeom SK; Lee SH; Chung HH; Hyun JJ
Clin Imaging; 2016; 40(3):548-52. PubMed ID: 27133702
[TBL] [Abstract][Full Text] [Related]
10. Assessment of main pancreatic duct cutoff with dilatation, but without visible pancreatic focal lesion on MDCT: a novel diagnostic approach for malignant stricture using a CT-based nomogram.
Lim CY; Min JH; Hwang JA; Choi SY; Ko SE
Eur Radiol; 2022 Dec; 32(12):8285-8295. PubMed ID: 35726102
[TBL] [Abstract][Full Text] [Related]
11. Isolated Main Pancreatic Duct Dilatation: CT Differentiation Between Benign and Malignant Causes.
Kim SW; Kim SH; Lee DH; Lee SM; Kim YS; Jang JY; Han JK
AJR Am J Roentgenol; 2017 Nov; 209(5):1046-1055. PubMed ID: 28858540
[TBL] [Abstract][Full Text] [Related]
12. Main duct and mixed type intraductal papillary mucinous neoplasms without enhancing mural nodules: Duct diameter of less than 10 mm and segmental dilatation of main pancreatic duct are findings support surveillance rather than immediate surgery.
Kim TH; Song TJ; Lee SO; Park CH; Moon JH; Pih GY; Oh DW; Woo SM; Yang YJ; Kim MH
Pancreatology; 2019 Dec; 19(8):1054-1060. PubMed ID: 31611130
[TBL] [Abstract][Full Text] [Related]
13. CT Abnormalities of the Pancreas Associated With the Subsequent Diagnosis of Clinical Stage I Pancreatic Ductal Adenocarcinoma More Than 1 Year Later: A Case-Control Study.
Toshima F; Watanabe R; Inoue D; Yoneda N; Yamamoto T; Sasahira N; Sasaki T; Matsuyama M; Minehiro K; Tateishi U; Gabata T
AJR Am J Roentgenol; 2021 Dec; 217(6):1353-1364. PubMed ID: 34161128
[No Abstract] [Full Text] [Related]
14. Cost-effectiveness of pancreas surveillance: The CDKN2A-p16-Leiden cohort.
Ibrahim IS; Vasen HFA; Wasser MNJM; Feshtali S; Bonsing BA; Morreau H; Inderson A; de Vos Tot Nederveen Cappel WH; van den Hout WB
United European Gastroenterol J; 2023 Mar; 11(2):163-170. PubMed ID: 36785917
[TBL] [Abstract][Full Text] [Related]
15. Incidental findings in pancreas screening programs for high-risk individuals: Results from three European expert centers.
Ibrahim IS; Brückner C; Carrato A; Earl J; Inderson A; de Vos Tot Nederveen Cappel WH; Mintziras I; Matthäi E; Figiel J; Wasser M; Moreau H; Bonsing B; Slater EP; Bartsch DK; Vasen HF
United European Gastroenterol J; 2019 Jun; 7(5):682-688. PubMed ID: 31210946
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of non-contrast MR imaging in distinguishing pancreatic ductal adenocarcinoma from focal pancreatitis.
Lee JH; Min JH; Kim YK; Cha DI; Lee J; Park HJ; Ahn S
Clin Imaging; 2019; 55():132-139. PubMed ID: 30818163
[TBL] [Abstract][Full Text] [Related]
17. Image of the month. Papillary low-grade neuroendocrine tumor of the pancreas with pancreatic duct dilation.
Martin RC; D'Angelica M; Blumgart LH
Arch Surg; 2005 Mar; 140(3):311-2. PubMed ID: 15781798
[No Abstract] [Full Text] [Related]
18. Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance.
Canto MI; Almario JA; Schulick RD; Yeo CJ; Klein A; Blackford A; Shin EJ; Sanyal A; Yenokyan G; Lennon AM; Kamel IR; Fishman EK; Wolfgang C; Weiss M; Hruban RH; Goggins M
Gastroenterology; 2018 Sep; 155(3):740-751.e2. PubMed ID: 29803839
[TBL] [Abstract][Full Text] [Related]
19. Importance of main pancreatic duct dilatation in IPMN undergoing surveillance.
Marchegiani G; Andrianello S; Morbin G; Secchettin E; D'Onofrio M; De Robertis R; Malleo G; Bassi C; Salvia R
Br J Surg; 2018 Dec; 105(13):1825-1834. PubMed ID: 30106195
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic Cancer Surveillance in Carriers of a Germline
Klatte DCF; Boekestijn B; Wasser MNJM; Feshtali Shahbazi S; Ibrahim IS; Mieog JSD; Luelmo SAC; Morreau H; Potjer TP; Inderson A; Boonstra JJ; Dekker FW; Vasen HFA; van Hooft JE; Bonsing BA; van Leerdam ME
J Clin Oncol; 2022 Oct; 40(28):3267-3277. PubMed ID: 35658523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
